PREVACID-L CAPSULE

Product Overview

PREVACID-L CAPSULE contains Pantoprazole 40 mg + Sustained Release Levosulpiride 75 mg and is presented as an enteric-coated and sustained-release capsule in a 10 × 10 Alu-Alu pack, containing 100 capsules.

The formulation combines pantoprazole with sustained-release levosulpiride and is positioned within the gastrointestinal pharmaceutical range. PREVACID-L is suitable for pharmaceutical distributors, stockists, retailers, healthcare trade professionals and prospective franchise applicants who need to verify the exact composition, dosage form and pack presentation before making a business enquiry.

Composition

• Pantoprazole 40 mg
• Levosulpiride 75 mg — Sustained Release
• Dosage form: Capsule
• Release characteristics: Enteric Coated + Sustained Release
• Pack size: 10 × 10 Capsules
• Total quantity: 100 Capsules
• Packing: Alu-Alu
• MRP: ₹1,750/- per 100 capsules

Availability and Franchise Enquiries

Contact the Positive Medicare team for the latest pack presentation, order quantity, territory availability and commercial terms. Pharmaceutical distributors, stockists, retailers and prospective franchise partners can enquire about product availability and related pharmaceutical business opportunities.

Important: This page is intended for healthcare professionals and pharmaceutical business enquiries. It does not provide individual treatment, dosage or prescription advice. Prescription products should be used only under the direction of a qualified healthcare professional and according to approved product labelling.